Erste Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Hold |
140,225
| – | – | 0.05% | 251 |
|
|
2025
Q1 | $4.92M | Hold |
140,225
| – | – | 0.06% | 227 |
|
|
2024
Q4 | $3.92M | Hold |
140,225
| – | – | 0.05% | 258 |
|
|
2024
Q3 | $3.5M | Hold |
140,225
| – | – | 0.04% | 270 |
|
|
2024
Q2 | $3.53M | Buy |
140,225
+33,000
| +31% | +$832K | 0.05% | 260 |
|
|
2024
Q1 | $3.31M | Buy |
107,225
+23,000
| +27% | +$710K | 0.05% | 263 |
|
|
2023
Q4 | $3.52M | Buy |
84,225
+16,000
| +23% | +$669K | 0.05% | 252 |
|
|
2023
Q3 | $1.85M | Hold |
68,225
| – | – | 0.03% | 283 |
|
|
2023
Q2 | $1.16M | Hold |
68,225
| – | – | 0.02% | 348 |
|
|
2023
Q1 | $1.17M | Buy |
68,225
+30,000
| +78% | +$515K | 0.02% | 336 |
|
|
2022
Q4 | $289K | Hold |
38,225
| – | – | 0.01% | 463 |
|
|
2022
Q3 | $390K | Hold |
38,225
| – | – | 0.01% | 442 |
|
|
2022
Q2 | $338K | Hold |
38,225
| – | – | 0.01% | 468 |
|
|
2022
Q1 | $396K | Sell |
38,225
-19,000
| -33% | -$197K | 0.01% | 457 |
|
|
2021
Q4 | $812K | Hold |
57,225
| – | – | 0.01% | 381 |
|
|
2021
Q3 | $2.73M | Sell |
57,225
-19,200
| -25% | -$914K | 0.05% | 253 |
|
|
2021
Q2 | $4.59M | Hold |
76,425
| – | – | 0.09% | 211 |
|
|
2021
Q1 | $4.52M | Buy |
76,425
+19,425
| +34% | +$1.15M | 0.11% | 190 |
|
|
2020
Q4 | $3.85M | Hold |
57,000
| – | – | 0.11% | 192 |
|
|
2020
Q3 | $2.11M | Hold |
57,000
| – | – | 0.07% | 239 |
|
|
2020
Q2 | $1.86M | Hold |
57,000
| – | – | 0.07% | 242 |
|
|
2020
Q1 | $1.52M | Hold |
57,000
| – | – | 0.09% | 211 |
|
|
2019
Q4 | $2.1M | Buy |
57,000
+34,000
| +148% | +$1.25M | 0.09% | 204 |
|
|
2019
Q3 | $463K | Buy |
+23,000
| New | +$463K | 0.02% | 326 |
|